Article contents
Are the Triptans for Migraine Therapy Worth the Cost?
Published online by Cambridge University Press: 04 August 2016
Abstract:
The triptans represent a major advance in migraine therapy but their cost per dose greatly exceeds that of many older treatments. There is evidence that for a significant proportion of migraine patients these new drugs can show a positive cost benefit and also improve quality of life. Cost benefit would be expected to be greatest in patients with more severe migraine attacks.
- Type
- Review Article
- Information
- Copyright
- Copyright © The Canadian Journal of Neurological 2000
References
REFERENCES
- 5
- Cited by